MREO Earnings & Financial Statements
Mereo BioPharma Group plc
$0.31
-$0.01(-3.28%)
42
Overall
60
Value
41
Tech
26
Quality
Market Cap
$49.40M
Volume
887.87K
52W Range
$0.20 - $0.78
Target Price
$1.75
MREO earnings and financial statements: Mereo BioPharma Group plc's income statement, balance sheet and cash flow statement, annual and quarterly.
MREO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2024 | 2024 |
|---|---|---|---|---|
| Operating income | -$11.20M | -$47.36M | -$9.37M | -$9.90M |
| EBITDA | -$12.44M | -$40.80M | -$14.65M | -$8.70M |
| Net income | -$12.89M | -$43.25M | -$15.00M | -$9.28M |
| EPS (diluted) | $-0.10 | $-0.30 | $-0.10 | $-0.01 |
| Fiscal year | 2025 | 2024 | 2024 | 2024 |
|---|---|---|---|---|
| Total assets | $68.32M | $76.39M | $88.75M | $55.94M |
| Total liabilities | $8.24M | $15.42M | $16.21M | $13.10M |
| Shareholders’ equity | $60.08M | $60.97M | $72.54M | $42.84M |
| Cash and equivalents | $62.48M | $69.80M | $80.52M | $48.66M |
| Long-term debt | - | $187.0K | $394.0K | $727.0K |
| Fiscal year | 2025 | 2024 | 2024 | 2024 |
|---|---|---|---|---|
| Operating cash flow | -$8.33M | -$32.83M | -$23.41M | $3.90M |
| Free cash flow | -$8.65M | -$33.53M | -$24.11M | $3.20M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MREO | $0.31 | -3.3% | 887.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mereo BioPharma Group plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW